MARKET

SIGY

SIGY

Sigyn Therapeutics Inc
OTCPK
0.030
+0.009
+42.86%
Closed 15:25 08/24 EDT
OPEN
0.030
PREV CLOSE
0.021
HIGH
0.030
LOW
0.030
VOLUME
300
TURNOVER
9
52 WEEK HIGH
5.00
52 WEEK LOW
0.011
MARKET CAP
161.98K
P/E (TTM)
-0.0149
1D
5D
1M
3M
1Y
5Y
1D
Q2 Virtual Investor Summit Presentations Now Available On Demand
Barchart · 06/30 12:20
Q2 Investor Summit Virtual Live Wednesday June 24
Barchart · 06/23 14:40
Oragenics Signs LOI To License Certain Disease Indications Of CardioDialysis, Blood Purification Technology, From Sigyn Therapeutics
Benzinga · 05/07 12:34
Sigyn Therapeutics Delays Annual SEC Filing
TipRanks · 04/01 01:45
Signet Jewelers Introduces FY27 Guidance
NASDAQ · 03/19 12:36
Signet Jewelers Limited Bottom Line Advances In Q4
NASDAQ · 03/19 11:03
Signet Jewelers Revises Q4, FY26 Outlook; Expects Results In Upper Half Of Outlook Range
NASDAQ · 03/09 11:08
Sigyn Therapeutics Secures Funding via New Convertible Notes
TipRanks · 02/20 19:57
More
About SIGY
Sigyn Therapeutics, Inc. develops medical devices to treat cancer and infectious disease disorders. The Company's lead therapeutic candidate, Sigyn Therapy, is a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders. Candidate treatment indications include endotoxemia and inflammation in end-stage renal disease (dialysis) patients, sepsis (a cause of hospital deaths), community-acquired pneumonia (a cause of death among infectious diseases), and emerging pandemic threats. Sigyn Therapy is a single-use disposable device that is deployable on the global infrastructure of hemodialysis and continuous renal replacement therapy machines. Its development pipeline includes a cancer treatment system comprised of ChemoPrep to enhance the tumor site delivery of chemotherapy, and ChemoPure to reduce treatment toxicity and inhibit the spread of cancer metastasis. Its ImmunePrep platform enhances the performance of immunotherapeutic antibodies.

Webull offers Sigyn Therapeutics Inc stock information, including OTCPK: SIGY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SIGY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SIGY stock methods without spending real money on the virtual paper trading platform.